Savulescu-Fiedler Ilinca, Baz Radu Octavian, Baz Radu Andrei, Scheau Cristian, Gegiu Andrei
Department of Internal Medicine, The "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Internal Medicine and Cardiology, Coltea Clinical Hospital, 030167 Bucharest, Romania.
Life (Basel). 2025 Apr 3;15(4):597. doi: 10.3390/life15040597.
Coronary artery spasm (CAS) is a reversible vasoconstriction of normal or atherosclerotic epicardial coronary arteries with a subsequent reduction in myocardial blood flow, leading to myocardial ischemia, myocardial infarction, severe arrhythmias, or even sudden death. It is an entity that should be recognized based on a particular clinical presentation. Numerous differences exist between CAS and obstructive coronary disease in terms of mechanisms, risk factors, and therapeutic solutions. The gold standard for CAS diagnosis is represented by transitory and reversible occlusion of the coronary arteries at spasm provocation test, which consists of an intracoronary administration of Ach, ergonovine, or methylergonovine during angiography. The pathophysiology of CAS is not fully understood. However, the core of CAS is represented by vascular smooth muscle cell contraction, with a circadian pattern. The initiating event of this contraction may be represented by endothelial dysfunction, inflammation, or autonomic nervous system unbalance. Our study explores the intricate balance of these factors and their clinical relevance in the management of CAS.
冠状动脉痉挛(CAS)是正常或动脉粥样硬化的心外膜冠状动脉发生的可逆性血管收缩,随后心肌血流减少,导致心肌缺血、心肌梗死、严重心律失常,甚至猝死。它是一种应根据特定临床表现来识别的病症。CAS与阻塞性冠状动脉疾病在机制、危险因素和治疗方案方面存在诸多差异。CAS诊断的金标准是在痉挛激发试验中冠状动脉出现短暂且可逆的闭塞,该试验包括在血管造影期间冠状动脉内注射乙酰胆碱、麦角新碱或甲基麦角新碱。CAS的病理生理学尚未完全阐明。然而,CAS的核心是血管平滑肌细胞收缩,且具有昼夜节律模式。这种收缩的起始事件可能是内皮功能障碍、炎症或自主神经系统失衡。我们的研究探讨了这些因素的复杂平衡及其在CAS管理中的临床相关性。